United Kingdom In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to the UK In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in the UK

Scope

- The report provides information on the UK in vitro diagnostics market, broken down into detailed categories and segments such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology, Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.
- Total revenues, end users
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the in vitro diagnostics devices market in United Kingdom.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
 

Ventana Medical Systems, Inc.
Sysmex Corporation
Siemens Healthcare
Qiagen N.V.
Phadia AB
Ortho-Clinical Diagnostics Inc.
OLYMPUS CORPORATION
Inverness Medical Innovations, Inc.
Hologic, Inc.
Gen-Probe Incorporated
F. Hoffmann-La Roche Ltd.
DiaSorin S.p.A
Dade Behring Holdings, Inc.
Bio-Rad Laboratories, Inc.
bioMerieux S.A.
Becton, Dickinson and Company
Beckman Coulter, Inc.
Abbott Laboratories
Cozart Bioscience Ltd
Axis-Shield plc
The Binding Site Limited
Cambridge Theranostics Ltd.
Oxford Nanopore Technologies Ltd.
Guildhay Limited
Enigma Diagnostics Limited
Osmetech plc
Adjuvantix Limited
Genesis Diagnostics Ltd
AbD Serotec
Bioline Ltd.
Vivacta Limited
DxS Ltd.
g-Nostics Ltd.
Oxonica plc
Crescent Diagnostics Ltd.
Atlas Genetics Ltd.
 

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report
3.1 In Vitro Diagnostics
3.2 Clinical Chemistry
3.3 Genetic Testing
3.4 Haematology
3.5 Histology And Cytology
3.6 Immuno Chemistry
3.7 Infectious Immunology
3.8 Microbiology Culture
4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.3 Healthcare Policy
4.4 United Kingdom Healthcare Trade Statistics
5 Regulation System
5.1 Medical Equipment Approval Process
5.2 Medical Device approval fee
5.3 Post Market Surveillance (PMS)
6 Pricing and Reimbursement
6.1 Market Pricing
6.2 Government Policies for Reimbursement
7 Distribution Structure
8 In Vitro Diagnostics In United Kingdom
8.1 In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), 2000-2015
8.2 In Vitro Diagnostics, United Kingdom, Company Share (2007-2008)
9 Clinical Chemistry In United Kingdom
9.1 Clinical Chemistry Overall Revenue (2000-2015)
9.2 Clinical Chemistry Distribution Share (2007-2008)
9.3 Clinical Chemistry, United Kingdom, Company Share (2007-2008)
10 Genetic Testing In United Kingdom
10.1 Genetic Testing Overall Revenue (2000-2015)
10.2 Genetic Testing Distribution Share (2007-2008)
10.3 Genetic Testing, United Kingdom, Company Share (2007-2008)
11 Haematology In United Kingdom
11.1 Haematology Overall Revenue (2000-2015)
11.2 Haematology Distribution Share (2007-2008)
11.3 Haematology, United Kingdom, Company Share (2007-2008)
12 Histology and Cytology In United Kingdom
12.1 Histology and Cytology Overall Revenue (2000-2015)
12.2 Histology and Cytology Distribution Share (2007-2008)
12.3 Histology and Cytology, United Kingdom, Company Share (2007-2008)
13 Immuno Chemistry In United Kingdom
13.1 Immuno Chemistry Overall Revenue (2000-2015)
13.2 Immuno Chemistry Distribution Share (2007-2008)
13.3 Immuno Chemistry, United Kingdom, Company Share (2007-2008)
14 Infectious Immunology In United Kingdom
14.1 Infectious Immunology Overall Revenue (2000-2015)
14.2 Infectious Immunology Distribution Share (2007-2008)
14.3 Infectious Immunology, United Kingdom, Company Share (2007-2008)
15 Microbiology Culture In United Kingdom
15.1 Microbiology Culture Overall Revenue (2000-2015)
15.2 Microbiology Culture Distribution Share (2007-2008)
15.3 Microbiology Culture, United Kingdom, Company Share (2007-2008)
16 Overview of Key Companies in United Kingdom In Vitro Diagnostics Market
16.1 Ventana Medical Systems, Inc.
16.2 Sysmex Corporation
16.3 Siemens Healthcare
16.4 Qiagen N.V.
16.5 Phadia AB
16.6 Ortho-Clinical Diagnostics Inc.
16.7 OLYMPUS CORPORATION
16.8 Inverness Medical Innovations, Inc.
16.9 Hologic, Inc.
16.10 Gen-Probe Incorporated
16.11 F. Hoffmann-La Roche Ltd.
16.12 DiaSorin S.p.A
16.13 Dade Behring Holdings, Inc.
16.14 Bio-Rad Laboratories, Inc.
16.15 bioMerieux S.A.
16.16 Becton, Dickinson and Company
16.17 Beckman Coulter, Inc.
16.18 Abbott Laboratories
16.19 Cozart Bioscience Ltd
16.20 Axis-Shield plc
16.21 The Binding Site Limited
16.22 Cambridge Theranostics Ltd.
16.23 Oxford Nanopore Technologies Ltd.
16.24 Guildhay Limited
16.25 Enigma Diagnostics Limited
16.26 Osmetech plc
16.27 Adjuvantix Limited
16.28 Genesis Diagnostics Ltd
16.29 AbD Serotec
16.30 Bioline Ltd.
16.31 Vivacta Limited
16.32 DxS Ltd.
16.33 g-Nostics Ltd.
16.34 Oxonica plc
16.35 Crescent Diagnostics Ltd.
16.36 Atlas Genetics Ltd.
17 Financial Deals Landscape
17.1 Acquisition
17.2 Partnerships
18 Recent Developments
18.1 Strategy And Business Planning
18.2 Government and Public Interest
18.3 Product News
18.4 Other Significant Developments
19 Appendix
19.1 Global Markets Direct Research Methodology
19.2 Secondary Research
19.3 Primary Research
19.4 Models
19.5 Forecasts
19.6 Expert Panel Validation
19.7 Currency Conversion
19.8 Contact Us
19.9 Disclaimer
 

1.1 List of Tables
Table 1: Total Healthcare Expenditure, United Kingdom, 2000 – 2007 31
Table 2: Number of Doctor by Specialty in UK, 2003 - 2007 34
Table 3: United Kingdom Healthcare Trade Statistics, 2001-2006 36
Table 4: Medical Device Approval Fee in UK, 2006 50
Table 5: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), 2000-2015 54
Table 6: In Vitro Diagnostics, United Kingdom, Cross-Category Analysis, 2000-2015 55
Table 7: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), Historic, 2000-2008 57
Table 8: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), Forecast, 2008-2015 59
Table 9: In Vitro Diagnostics, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 60
Table 10: Clinical Chemistry, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008 62
Table 11: Clinical Chemistry, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015 64
Table 12: Clinical Chemistry Analyzers, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 65
Table 13: Clinical Chemistry Analyzers, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 66
Table 14: Urine Analysis, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 67
Table 15: Urine Analysis, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 68
Table 16: Clinical Chemistry, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008 69
Table 17: Clinical Chemistry, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 70
Table 18: Genetic Testing, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008 71
Table 19: Genetic Testing, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015 72
Table 20: Genetic Testing, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008 73
Table 21: Genetic Testing, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 74
Table 22: Haematology, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008 76
Table 23: Haematology, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015 78
Table 24: Haematology Reagents, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 79
Table 25: Haematology Reagents, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 80
Table 26: Immunohaematology, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 81
Table 27: Immunohaematology, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 82
Table 28: Haemostasis, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 84
Table 29: Haemostasis, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 86
Table 30: Haematology Rapid Tests, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 87
Table 31: Haematology Rapid Tests, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 88
Table 32: Haematology Cell Counters, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 89
Table 33: Haematology Cell Counters, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 90
Table 34: Haematology, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008 91
Table 35: Haematology, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 93
Table 36: Histology And Cytology, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2008 94
Table 37: Histology And Cytology, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2008-2015 95
Table 38: Histology, United Kingdom, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 96
Table 39: Histology, United Kingdom, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 97